Colorectal Cancer and Stem cells
Colorectal Cancer remains a significant cause of cancer – related mortality worldwide, mainly because of tumour relapse and metastases. Cancer stem cells are considered to be main cause of resistance to chemotherapeutic agents, as well as being responsible for distant metastases. Although CSCs themselves possess innate abilities for self-renewal and differentiation, the environment surrounding CSCs provides oxygen, nutrients and secreted factors and also supports angiogenesis, thus it is responsible for maintaining their CSC properties. Extensive investigation has revealed that obesity and induced chronic inflammation is linked to risk and progression of evidence linking colorectal CSCs and environment and summarizes our current understanding of the molecular mechanisms underlying the relationships.
Related Conference of Colorectal Cancer and Stem cells
April 13-14, 2026
23rd International Conference on Breast Pathology and Cancer Diagnosis
Tokyo, Japan
September 29-30, 2026
5th Experts Meeting on Cancer Medicine, Radiology & Treatment
Aix-en-Provence, France
Colorectal Cancer and Stem cells Conference Speakers
Recommended Sessions
- Blood Cancer
- Brain Tumours
- Breast Cancer
- Breast Cancer and New Innovations in Treatment
- Cancer Chemotherapy
- Cancer Diagnosis
- Cancer Immunotherapy
- Cancer Surgery
- Clinical Trials on Cancer treatments
- Colorectal Cancer and Stem cells
- Gastrointestinal Cancer
- Genetic-based Biomarkers and Next-Generation Sequencing (NGS)
- Leukemia
- Medical Oncology
- Ovarian Cancer
Related Journals
Are you interested in
- Advancement in the Field of Cancer - CANCER THERAPY MEETING 2026 (France)
- Advancements in Early Detection and Screening - Euro Breast Cancer 2025 (France)
- Advances in Breast Cancer Diagnosis - Breast Cancer Summit 2026 (France)
- Advances in Immuno-Oncology - CANCER THERAPY MEETING 2026 (France)
- Advances in Pediatric Oncology Imaging & Therapy - Cancer Meeting Summit 2026 (France)
- Advances in Supportive Care and Symptom Management - CANCER THERAPY MEETING 2026 (France)
- AI and Machine Learning in Cancer Diagnosis - Cancer Meeting Summit 2026 (France)
- AI-Driven Treatment Planning and Workflow Optimization - Cancer Meeting Summit 2026 (France)
- Alternative Treatments and Therapeutics - Cancer Science 2026 (UAE)
- Artificial Intelligence & Big Data in Breast Oncology - Breast Cancer Summit 2026 (France)
- Artificial Intelligence and Big Data in Cancer Research - CANCER THERAPY MEETING 2026 (France)
- Artificial Intelligence and Digital Health in Oncology - Euro Breast Cancer 2025 (France)
- Artificial Intelligence in Breast Imaging - Breast Cancer-2026 (Italy)
- Breakthroughs in Precision Cancer Treatments - Cancer Meeting Summit 2026 (France)
- Breast Cancer - Cancer Science 2026 (UAE)
- Breast Cancer and Cell Biology - Breast Cancer 2026 (UAE)
- Breast Cancer and Immunology - Breast Cancer 2026 (UAE)
- Breast Cancer and Pregnancy - Breast Cancer Summit 2026 (France)
- Breast Cancer Awareness - Breast Cancer 2026 (UAE)
- Breast Cancer Biomarkers and Prognosis - Breast Cancer-2026 (Italy)
- Breast Cancer Clinical Trials - Breast Cancer 2026 (UAE)
- Breast Cancer Detection, Prevention, and Diagnosis - Breast Cancer 2026 (UAE)
- Breast Cancer Imaging and Radiology - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer-2026 (Italy)
- Breast Cancer in Young Women - Breast Cancer Summit 2026 (France)
- Breast Cancer in Young Women - Euro Breast Cancer 2025 (France)
- Breast Cancer Management - Breast Cancer 2026 (UAE)
- Breast Cancer Nursing - Breast Cancer 2026 (UAE)
- Breast Cancer Prevention and Lifestyle - Breast Cancer Summit 2026 (France)
- Breast Cancer Prevention and Risk Reduction - Euro Breast Cancer 2025 (France)
- Breast Cancer Prevention Strategies - Breast Cancer-2026 (Italy)
- Breast Cancer Risk - Breast Cancer 2026 (UAE)
- Breast Cancer Staging - Breast Cancer 2026 (UAE)
- Breast Cancer Surgery - Breast Cancer 2026 (UAE)
- Breast Cancer Survivorship and Quality of Life - Breast Cancer-2026 (Italy)
- Breast Cancer Types and Etiology - Breast Cancer 2026 (UAE)
- Breast Reconstruction and Cosmetic Outcomes - Breast Cancer Summit 2026 (France)
- Breast Reconstruction and Cosmetic Surgery - Breast Cancer-2026 (Italy)
- Cancer Care in the Era of Digital Health - CANCER THERAPY MEETING 2026 (France)
- Cancer Cell Biology & Genetics - Cancer Meeting Summit 2026 (France)
- Cancer Control and Prevention - Cancer Science 2026 (UAE)
- Cancer Early Detection, Diagnosis and Prognosis - Cancer Meeting Summit 2026 (France)
- Cancer Epidemiology and Prevention - CANCER THERAPY MEETING 2026 (France)
- Cancer Epigenetics - Cancer Science 2026 (UAE)
- Cancer Genomics & Metabolomics - CANCER THERAPY MEETING 2026 (France)
- Cancer Immunology - CANCER THERAPY MEETING 2026 (France)
- Cancer Metabolism and Therapeutic Interventions - CANCER THERAPY MEETING 2026 (France)
- Cancer Metastasis - Cancer Science 2026 (UAE)
- Cancer Science - Cancer Science 2026 (UAE)
- Cancer Screening & Chemotherapy - Cancer Meeting Summit 2026 (France)
- Cancer Stem Cells: Understanding and Targeting - CANCER THERAPY MEETING 2026 (France)
- Cancer Survivorship and Quality of Life - CANCER THERAPY MEETING 2026 (France)
- Cancer Vaccines - CANCER THERAPY MEETING 2026 (France)
- Cancer Vaccines - Cancer Meeting Summit 2026 (France)
- Cancers Biomarkers - Cancer Science 2026 (UAE)
- Cancers Pharmacology - Cancer Science 2026 (UAE)
- Case Studies - Breast Cancer 2026 (UAE)
- Cell-Based Therapy - CANCER THERAPY MEETING 2026 (France)
- Clinical Trials and New Drug Development - CANCER THERAPY MEETING 2026 (France)
- Diet and Lifestyle Effects on Breast Cancer - Breast Cancer 2026 (UAE)
- DNA Damage, Mutation and Cancer - Cancer Meeting Summit 2026 (France)
- Drug Development and Clinical Trials in Breast Cancer - Euro Breast Cancer 2025 (France)
- Drug Resistance and Overcoming Challenges - CANCER THERAPY MEETING 2026 (France)
- Early Detection and Biomarker-Driven Care - Cancer Meeting Summit 2026 (France)
- Emerging Radiopharmaceuticals and Molecular Imaging - Cancer Meeting Summit 2026 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2026 (UAE)
- Ethical and Regulatory Issues in Cancer Research - CANCER THERAPY MEETING 2026 (France)
- Future Directions in Cancer Therapy and Research - CANCER THERAPY MEETING 2026 (France)
- Genetic Predisposition and BRCA Mutations - Breast Cancer Summit 2026 (France)
- Genomic Profiling for Personalized Cancer Care - Cancer Meeting Summit 2026 (France)
- Global Disparities and Access to Breast Cancer Care - Euro Breast Cancer 2025 (France)
- Global Innovations in Cancer Care Delivery & Accessibility - Cancer Meeting Summit 2026 (France)
- Hematology- Oncology - Cancer Science 2026 (UAE)
- HER2-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- HER2-Positive Breast Cancer Advances - Breast Cancer-2026 (Italy)
- HER2-Positive Breast Cancer: Latest Treatment Strategies - Euro Breast Cancer 2025 (France)
- Hormone Receptor-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- Hormone Receptor-Positive Breast Cancer - Euro Breast Cancer 2025 (France)
- Hormone Receptor-Positive Subtypes - Breast Cancer-2026 (Italy)
- Immunotherapy and Breast Cancer - Breast Cancer-2026 (Italy)
- Immunotherapy and Emerging Targeted Therapies - Euro Breast Cancer 2025 (France)
- Immunotherapy and Novel Therapeutic Approaches - Cancer Meeting Summit 2026 (France)
- Immunotherapy in Breast Cancer - Breast Cancer-2026 (Italy)
- Improved Survivorship Care and Quality-of-Life Strategies - Cancer Meeting Summit 2026 (France)
- Inflammatory Breast Cancer - Breast Cancer 2026 (UAE)
- Innovations in Breast Cancer Treatment - Breast Cancer Summit 2026 (France)
- Innovations in Cancer Data and Informatics - CANCER THERAPY MEETING 2026 (France)
- Innovative Approaches in Cancer Radiology - CANCER THERAPY MEETING 2026 (France)
- Integrating Multidisciplinary Strategies in Cancer Care - Cancer Meeting Summit 2026 (France)
- Integration of Patient-Reported Outcomes in Cancer therapy - CANCER THERAPY MEETING 2026 (France)
- Integrative Oncology for Holistic Patient Support - Cancer Meeting Summit 2026 (France)
- Liquid Biopsies and Non-Invasive Diagnostic Tools - Cancer Meeting Summit 2026 (France)
- Liquid Biopsy and Early Cancer Detection - CANCER THERAPY MEETING 2026 (France)
- Liquid Biopsy and Non-Invasive Diagnostics - Breast Cancer-2026 (Italy)
- Male Breast Cancer Research - Breast Cancer 2026 (UAE)
- Mammography - Breast Cancer 2026 (UAE)
- Metastatic Breast Cancer Management - Breast Cancer-2026 (Italy)
- Metastatic Breast Cancer: Quality of Life and Care - Euro Breast Cancer 2025 (France)
- Minimally Invasive Image-Guided Interventions - Cancer Meeting Summit 2026 (France)
- Molecular Diagnostics and Biomarkers in Cancer - CANCER THERAPY MEETING 2026 (France)
- Nanotechnology in Cancer Diagnosis and Treatment - CANCER THERAPY MEETING 2026 (France)
- Neoadjuvant and Adjuvant Therapies - Breast Cancer-2026 (Italy)
- Neonatal & Pediatric Oncology - Cancer Meeting Summit 2026 (France)
- Next-Generation Imaging & Radiology Techniques - Cancer Meeting Summit 2026 (France)
- Oncogenomics - Cancer Science 2026 (UAE)
- Oncology Nursing and Care - Cancer Science 2026 (UAE)
- Oncology Nursing: Advancements in Patient Care - CANCER THERAPY MEETING 2026 (France)
- Oncology Radiology, Nanotechnology - Cancer Meeting Summit 2026 (France)
- Organic Specific Cancer - Cancer Science 2026 (UAE)
- Pediatric Cancer Research and Therapeutics - CANCER THERAPY MEETING 2026 (France)
- Personalized Medicine & Targeted Therapies - Cancer Meeting Summit 2026 (France)
- Precision Medicine and Genomics in Breast Cancer - Euro Breast Cancer 2025 (France)
- Psychosocial Aspects of Breast Cancer - Breast Cancer-2026 (Italy)
- Psychosocial Support and Survivorship - Breast Cancer Summit 2026 (France)
- Psychosocial Support and Survivorship in Breast Cancer - Euro Breast Cancer 2025 (France)
- Psychotherapy and Cancer - CANCER THERAPY MEETING 2026 (France)
- Radiation Oncology Advances & Safety Innovations - Cancer Meeting Summit 2026 (France)
- Radiation Oncology in Breast Cancer - Breast Cancer-2026 (Italy)
- Radiation Oncology: Innovations and Techniques - CANCER THERAPY MEETING 2026 (France)
- Radiation Therapy and Technological Innovations - Euro Breast Cancer 2025 (France)
- Radiation Therapy in Breast Cancer - Breast Cancer Summit 2026 (France)
- Radiology - Breast Cancer 2026 (UAE)
- Real-Time Tumor Monitoring and Adaptive Therapies - Cancer Meeting Summit 2026 (France)
- Role of Microbiome in Cancer - CANCER THERAPY MEETING 2026 (France)
- Skin Cancer - Cancer Science 2026 (UAE)
- Surgical Advances in Breast Cancer Management - Euro Breast Cancer 2025 (France)
- Surgical Innovations in Breast Cancer - Breast Cancer-2026 (Italy)
- Surgical Oncology in Breast Cancer - Breast Cancer Summit 2026 (France)
- Targeted Therapy and Drug Development - Breast Cancer-2026 (Italy)
- Targeted Therapy and Precision Medicine - CANCER THERAPY MEETING 2026 (France)
- Theranostics: Combined Imaging and Treatment Approaches - Cancer Meeting Summit 2026 (France)
- Translational Research for Improved Patient Outcomes - Cancer Meeting Summit 2026 (France)
- Triple-Negative Breast Cancer (TNBC) - Breast Cancer Summit 2026 (France)
- Triple-Negative Breast Cancer Research - Breast Cancer-2026 (Italy)
- Triple-Negative Breast Cancer: Challenges and Innovations - Euro Breast Cancer 2025 (France)
- Tumor Biology - Cancer Science 2026 (UAE)
- Tumor Microenvironment and Metastasis - CANCER THERAPY MEETING 2026 (France)
- Tumor Virology - Cancer Science 2026 (UAE)
- Young Women and Breast Cancer - Breast Cancer-2026 (Italy)